(As of September 2021)
Development Pipelines
Product code | Target Indication | Dosage Form | Development region | Current Phase |
---|---|---|---|---|
M5120B | Superficial skin infection and Acne vulgaris | Topical | JP | Jan, 2021 Approval |
M7040B | Scalp eczema dermatitis | Topical | JP | Feb, 2021 Approval |
M1220 | Rosacea | Topical | JP | Filed for Approval |
M5250 | Pruritus with atopic dermatitis (adults) *PIII studies in progress for pediatric |
Injection | JP | Filed for Approval |
M6060 | Primary axillary hyperhidrosis | Topical | JP | Filed for Approval |
M1210 | Ingrown nails | Topical | JP | PIII |
M5220B | Recurrent herpes simplex | Oral | JP | PIII |
M5250B | Pruritus with prurigo nodularis | Injection | JP | PIII |
M6050E | Acne vulgaris | Topical | JP | PIII |
M1880C | Prurigo nodularis | Topical | JP | PII |
M6050C | Acne vulgaris | Topical | JP | PII |
- Product List
- Product Pipeline
- Business Partnerships
- Product Activities